ID   PTN11_RAT               Reviewed;         593 AA.
AC   P41499; Q62626;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-DEC-2019, sequence version 5.
DT   02-OCT-2024, entry version 209.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 11;
DE            EC=3.1.3.48 {ECO:0000269|PubMed:7512964};
DE   AltName: Full=Protein-tyrosine phosphatase 1D;
DE            Short=PTP-1D;
DE   AltName: Full=Protein-tyrosine phosphatase SYP;
DE   AltName: Full=SH-PTP2;
DE            Short=SHP-2;
DE            Short=Shp2;
GN   Name=Ptpn11;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=8048963; DOI=10.1006/bbrc.1994.2015;
RA   Ding W., Zhang W.R., Sullivan K., Hashimoto N., Goldstein B.J.;
RT   "Identification of protein-tyrosine phosphatases prevalent in adipocytes by
RT   molecular cloning.";
RL   Biochem. Biophys. Res. Commun. 202:902-907(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7512964; DOI=10.1016/s0021-9258(17)32709-6;
RA   Mei L., Dorherty C.A., Huganir R.L.;
RT   "RNA splicing regulates the activity of a SH2 domain-containing protein
RT   tyrosine phosphatase.";
RL   J. Biol. Chem. 269:12254-12262(1994).
RN   [3]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1382983; DOI=10.1111/j.1432-1033.1992.tb17277.x;
RA   Hiraga A., Munakata H., Hata K., Suzuki Y., Tsuiki S.;
RT   "Purification and characterization of a rat liver protein-tyrosine
RT   phosphatase with sequence similarity to src-homology region 2.";
RL   Eur. J. Biochem. 209:195-206(1992).
RN   [4]
RP   INTERACTION WITH PTPNS1.
RX   PubMed=8810330; DOI=10.1074/jbc.271.41.25569;
RA   Ohnishi H., Kubota M., Ohtake A., Sato K., Sano S.;
RT   "Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based
RT   activation motif of a novel brain molecule.";
RL   J. Biol. Chem. 271:25569-25574(1996).
RN   [5]
RP   INTERACTION WITH PTPNS1.
RX   PubMed=9062191; DOI=10.1038/386181a0;
RA   Kharitonenkov A., Chen Z., Sures I., Wang H., Schilling J., Ullrich A.;
RT   "A family of proteins that inhibit signalling through tyrosine kinase
RT   receptors.";
RL   Nature 386:181-186(1997).
RN   [6]
RP   INTERACTION WITH ROS1.
RX   PubMed=16885344; DOI=10.1158/0008-5472.can-06-1193;
RA   Charest A., Wilker E.W., McLaughlin M.E., Lane K., Gowda R., Coven S.,
RA   McMahon K., Kovach S., Feng Y., Yaffe M.B., Jacks T., Housman D.;
RT   "ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-
RT   2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling
RT   axis to form glioblastoma in mice.";
RL   Cancer Res. 66:7473-7481(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Acts downstream of various receptor and cytoplasmic protein
CC       tyrosine kinases to participate in the signal transduction from the
CC       cell surface to the nucleus (By similarity). Positively regulates MAPK
CC       signal transduction pathway (By similarity). Dephosphorylates GAB1,
CC       ARHGAP35 and EGFR (By similarity). Dephosphorylates ROCK2 at 'Tyr-722'
CC       resulting in stimulation of its RhoA binding activity (By similarity).
CC       Dephosphorylates CDC73 (By similarity). Dephosphorylates SOX9 on
CC       tyrosine residues, leading to inactivate SOX9 and promote ossification
CC       (By similarity). Dephosphorylates tyrosine-phosphorylated NEDD9/CAS-L
CC       (By similarity). {ECO:0000250|UniProtKB:P35235,
CC       ECO:0000250|UniProtKB:Q06124}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044, ECO:0000269|PubMed:7512964};
CC   -!- ACTIVITY REGULATION: Inhibited by orthovanadate, molybdate and
CC       spermidine. {ECO:0000269|PubMed:7512964}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=18 mM for pNPP (isoform 1) {ECO:0000269|PubMed:7512964};
CC         KM=48 uM for nAChR (isoform 1) {ECO:0000269|PubMed:7512964};
CC         KM=1.3 uM for MBP (isoform 1) {ECO:0000269|PubMed:7512964};
CC         KM=15 mM for pNPP (isoform 2) {ECO:0000269|PubMed:7512964};
CC         KM=13 uM for nAChR (isoform 2) {ECO:0000269|PubMed:7512964};
CC         KM=0.067 uM for MBP (isoform 2) {ECO:0000269|PubMed:7512964};
CC         Vmax=120 umol/min/mg enzyme toward pNPP (isoform 1)
CC         {ECO:0000269|PubMed:7512964};
CC         Vmax=220 nmol/min/mg enzyme toward nAChR (isoform 1)
CC         {ECO:0000269|PubMed:7512964};
CC         Vmax=210 nmol/min/mg enzyme toward MBP (isoform 1)
CC         {ECO:0000269|PubMed:7512964};
CC         Vmax=16 umol/min/mg enzyme toward pNPP (isoform 2)
CC         {ECO:0000269|PubMed:7512964};
CC         Vmax=98 nmol/min/mg enzyme toward nAChR (isoform 2)
CC         {ECO:0000269|PubMed:7512964};
CC         Vmax=15 nmol/min/mg enzyme toward MBP (isoform 2)
CC         {ECO:0000269|PubMed:7512964};
CC       pH dependence:
CC         Optimum pH is 7.0-7.5 (isoform 1). Optimum pH is 8.5 (isoform 2).
CC         {ECO:0000269|PubMed:7512964};
CC   -!- SUBUNIT: Interacts with phosphorylated SIT1, LIME1, BCAR3 and MZPL1.
CC       Interacts with FCRL4, FCRL6, ANKHD1, SHB, INPP5D/SHIP1 and CD84 (By
CC       similarity). Interacts with MILR1 (tyrosine-phosphorylated). Interacts
CC       with FLT1 (tyrosine-phosphorylated), FLT3 (tyrosine-phosphorylated),
CC       FLT4 (tyrosine-phosphorylated), KIT and GRB2 (By similarity). Interacts
CC       with PTPNS1. Interacts with KIR2DL1; the interaction is enhanced by
CC       ARRB2. Interacts (via SH2 domain) with TEK/TIE2 (tyrosine
CC       phosphorylated) (By similarity). Interacts with GAB2 (By similarity).
CC       Interacts with TERT; the interaction retains TERT in the nucleus.
CC       Interacts with PECAM1 and FER. Interacts with EPHA2 (activated);
CC       participates in PTK2/FAK1 dephosphorylation in EPHA2 downstream
CC       signaling. Interacts with PDGFRA (tyrosine phosphorylated). Interacts
CC       with PDGFRB (tyrosine phosphorylated); this interaction increases the
CC       PTPN11 phosphatase activity (By similarity). Interacts with ROS1; this
CC       mediates PTPN11 phosphorylation. Interacts with CEACAM1 (via
CC       cytoplasmic domain); this interaction depends on the monomer/dimer
CC       equilibrium and is phosphorylation-dependent (By similarity). Interacts
CC       with MPIG6B (via ITIM motif) (By similarity). Interacts with SIGLEC10
CC       (By similarity). Interacts with CLEC12B (via ITIM motif); this
CC       interaction triggers dephosphorylation and activation of PTPN11.
CC       Interacts (via SH2 domains) with NEDD9/CAS-L; the interaction is
CC       enhanced when NEDD9/CAS-L is tyrosine phosphorylated (By similarity).
CC       {ECO:0000250|UniProtKB:P35235, ECO:0000250|UniProtKB:Q06124,
CC       ECO:0000269|PubMed:16885344, ECO:0000269|PubMed:8810330,
CC       ECO:0000269|PubMed:9062191}.
CC   -!- INTERACTION:
CC       P41499; Q62689: Jak2; NbExp=3; IntAct=EBI-7180604, EBI-8656708;
CC       P41499; P97710: Sirpa; NbExp=3; IntAct=EBI-7180604, EBI-7945080;
CC       P41499; P09619: PDGFRB; Xeno; NbExp=4; IntAct=EBI-7180604, EBI-641237;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PTP1D;
CC         IsoId=P41499-2; Sequence=Displayed;
CC       Name=2; Synonyms=PTP1Di;
CC         IsoId=P41499-1; Sequence=VSP_060441;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, muscle and lung.
CC       {ECO:0000269|PubMed:7512964}.
CC   -!- DOMAIN: The SH2 domains repress phosphatase activity. Binding of these
CC       domains to phosphotyrosine-containing proteins relieves this auto-
CC       inhibition, possibly by inducing a conformational change in the enzyme.
CC   -!- PTM: Phosphorylated on Tyr-542 and Tyr-580 upon receptor protein
CC       tyrosine kinase activation; which creates a binding site for GRB2 and
CC       other SH2-containing proteins. Phosphorylated upon activation of the
CC       receptor-type kinase FLT3. Phosphorylated upon activation of the
CC       receptor-type kinase PDGFRA. Phosphorylated by activated PDGFRB (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class 2 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U09307; AAA20543.1; -; mRNA.
DR   EMBL; U05963; AAA19133.1; -; mRNA.
DR   PIR; A53593; A53593.
DR   RefSeq; NP_001171064.1; NM_001177593.1. [P41499-1]
DR   RefSeq; NP_037220.2; NM_013088.2. [P41499-2]
DR   AlphaFoldDB; P41499; -.
DR   SMR; P41499; -.
DR   BioGRID; 247651; 6.
DR   CORUM; P41499; -.
DR   DIP; DIP-47397N; -.
DR   ELM; P41499; -.
DR   IntAct; P41499; 31.
DR   MINT; P41499; -.
DR   STRING; 10116.ENSRNOP00000041842; -.
DR   iPTMnet; P41499; -.
DR   PhosphoSitePlus; P41499; -.
DR   jPOST; P41499; -.
DR   PaxDb; 10116-ENSRNOP00000041842; -.
DR   GeneID; 25622; -.
DR   KEGG; rno:25622; -.
DR   UCSC; RGD:3447; rat. [P41499-2]
DR   AGR; RGD:3447; -.
DR   CTD; 5781; -.
DR   RGD; 3447; Ptpn11.
DR   VEuPathDB; HostDB:ENSRNOG00000030124; -.
DR   eggNOG; KOG0790; Eukaryota.
DR   HOGENOM; CLU_001645_9_10_1; -.
DR   InParanoid; P41499; -.
DR   OrthoDB; 2911650at2759; -.
DR   PhylomeDB; P41499; -.
DR   TreeFam; TF351632; -.
DR   Reactome; R-RNO-1059683; Interleukin-6 signaling.
DR   Reactome; R-RNO-109704; PI3K Cascade.
DR   Reactome; R-RNO-110056; MAPK3 (ERK1) activation.
DR   Reactome; R-RNO-112411; MAPK1 (ERK2) activation.
DR   Reactome; R-RNO-114604; GPVI-mediated activation cascade.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-RNO-1433557; Signaling by SCF-KIT.
DR   Reactome; R-RNO-180292; GAB1 signalosome.
DR   Reactome; R-RNO-186763; Downstream signal transduction.
DR   Reactome; R-RNO-210990; PECAM1 interactions.
DR   Reactome; R-RNO-210993; Tie2 Signaling.
DR   Reactome; R-RNO-388841; Costimulation by the CD28 family.
DR   Reactome; R-RNO-389513; CTLA4 inhibitory signaling.
DR   Reactome; R-RNO-389948; PD-1 signaling.
DR   Reactome; R-RNO-432142; Platelet sensitization by LDL.
DR   Reactome; R-RNO-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-RNO-5654689; PI-3K cascade:FGFR1.
DR   Reactome; R-RNO-5654693; FRS-mediated FGFR1 signaling.
DR   Reactome; R-RNO-5654695; PI-3K cascade:FGFR2.
DR   Reactome; R-RNO-5654700; FRS-mediated FGFR2 signaling.
DR   Reactome; R-RNO-5654706; FRS-mediated FGFR3 signaling.
DR   Reactome; R-RNO-5654710; PI-3K cascade:FGFR3.
DR   Reactome; R-RNO-5654712; FRS-mediated FGFR4 signaling.
DR   Reactome; R-RNO-5654720; PI-3K cascade:FGFR4.
DR   Reactome; R-RNO-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-RNO-5654727; Negative regulation of FGFR2 signaling.
DR   Reactome; R-RNO-5654732; Negative regulation of FGFR3 signaling.
DR   Reactome; R-RNO-5654733; Negative regulation of FGFR4 signaling.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-8853659; RET signaling.
DR   Reactome; R-RNO-8854691; Interleukin-20 family signaling.
DR   Reactome; R-RNO-8865999; MET activates PTPN11.
DR   Reactome; R-RNO-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-RNO-912694; Regulation of IFNA/IFNB signaling.
DR   Reactome; R-RNO-936964; Activation of IRF3, IRF7 mediated by TBK1, IKKEpsilon (IKBKE).
DR   Reactome; R-RNO-9674555; Signaling by CSF3 (G-CSF).
DR   PRO; PR:P41499; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000030124; Expressed in Ammon's horn and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0045296; F:cadherin binding; ISO:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:RGD.
DR   GO; GO:0031748; F:D1 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0005158; F:insulin receptor binding; IDA:RGD.
DR   GO; GO:0043560; F:insulin receptor substrate binding; IPI:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0051428; F:peptide hormone receptor binding; ISO:RGD.
DR   GO; GO:0043274; F:phospholipase binding; IDA:RGD.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; ISO:RGD.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; IPI:RGD.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:RGD.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:RGD.
DR   GO; GO:0030159; F:signaling receptor complex adaptor activity; ISO:RGD.
DR   GO; GO:0036302; P:atrioventricular canal development; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0060020; P:Bergmann glial cell differentiation; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:1990314; P:cellular response to insulin-like growth factor stimulus; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IPI:RGD.
DR   GO; GO:0021697; P:cerebellar cortex formation; ISO:RGD.
DR   GO; GO:0000077; P:DNA damage checkpoint signaling; ISO:RGD.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0038127; P:ERBB signaling pathway; ISO:RGD.
DR   GO; GO:0060325; P:face morphogenesis; ISO:RGD.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048806; P:genitalia development; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISO:RGD.
DR   GO; GO:0042445; P:hormone metabolic process; ISO:RGD.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0048839; P:inner ear development; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0061582; P:intestinal epithelial cell migration; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0035855; P:megakaryocyte development; ISO:RGD.
DR   GO; GO:0032528; P:microvillus organization; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0033629; P:negative regulation of cell adhesion mediated by integrin; ISO:RGD.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0051463; P:negative regulation of cortisol secretion; ISO:RGD.
DR   GO; GO:0060125; P:negative regulation of growth hormone secretion; ISO:RGD.
DR   GO; GO:0046888; P:negative regulation of hormone secretion; ISO:RGD.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0032480; P:negative regulation of type I interferon production; ISO:RGD.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; ISO:RGD.
DR   GO; GO:0035265; P:organ growth; ISO:RGD.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0030220; P:platelet formation; ISO:RGD.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; IMP:RGD.
DR   GO; GO:0046326; P:positive regulation of glucose import; ISO:RGD.
DR   GO; GO:0046887; P:positive regulation of hormone secretion; ISO:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; ISO:RGD.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0045778; P:positive regulation of ossification; ISS:UniProtKB.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0009967; P:positive regulation of signal transduction; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0033628; P:regulation of cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0043408; P:regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0046825; P:regulation of protein export from nucleus; ISO:RGD.
DR   GO; GO:0043254; P:regulation of protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0048659; P:smooth muscle cell proliferation; IEP:RGD.
DR   GO; GO:0006641; P:triglyceride metabolic process; ISO:RGD.
DR   CDD; cd14605; PTPc-N11; 1.
DR   CDD; cd09931; SH2_C-SH2_SHP_like; 1.
DR   CDD; cd10340; SH2_N-SH2_SHP_like; 1.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR012152; Tyr_Pase_non-rcpt_typ-6/11.
DR   PANTHER; PTHR46559; TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11; 1.
DR   PANTHER; PTHR46559:SF1; TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11; 1.
DR   Pfam; PF00017; SH2; 2.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000929; Tyr-Ptase_nr_6; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SMART; SM00252; SH2; 2.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   SUPFAM; SSF55550; SH2 domain; 2.
DR   PROSITE; PS50001; SH2; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Hydrolase; Phosphoprotein; Protein phosphatase; Reference proteome; Repeat;
KW   SH2 domain.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q06124"
FT   CHAIN           2..593
FT                   /note="Tyrosine-protein phosphatase non-receptor type 11"
FT                   /id="PRO_0000094769"
FT   DOMAIN          6..102
FT                   /note="SH2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          112..216
FT                   /note="SH2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          247..517
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        459
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160,
FT                   ECO:0000255|PROSITE-ProRule:PRU10044"
FT   BINDING         425
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         459..465
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         506
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06124"
FT   MOD_RES         62
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         66
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35235"
FT   MOD_RES         542
FT                   /note="Phosphotyrosine; by PDGFR"
FT                   /evidence="ECO:0000250|UniProtKB:P35235"
FT   MOD_RES         580
FT                   /note="Phosphotyrosine; by PDGFR"
FT                   /evidence="ECO:0000250|UniProtKB:Q06124"
FT   VAR_SEQ         407
FT                   /note="G -> GQALL (in isoform 2)"
FT                   /id="VSP_060441"
FT   CONFLICT        75
FT                   /note="A -> P (in Ref. 1; AAA20543)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        547
FT                   /note="Y -> S (in Ref. 2; AAA19133)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   593 AA;  68033 MW;  3329F10F0F60AF48 CRC64;
     MTSRRWFHPN ITGVEAENLL LTRGVDGSFL ARPSKSNPGD FTLSVRRNGA VTHIKIQNTG
     DYYDLYGGEK FATLAELVQY YMEHHGQLKE KNGDVIELKY PLNCADPTSE RWFHGHLSGK
     EAEKLLTEKG KHGSFLVRES QSHPGDFVLS VRTGDDKGES NDSKSKVTHV MIRCQELKYD
     VGGGERFDSL TDLVEHYKKN PMVETLGTVL QLKQPLNTTR INAAEIESRV RELSKLAETT
     DKVKQGFWEE FETLQQQECK LLYSRKEGQR QENKNKNRYK NILPFDHTRV VLHDGDPNEP
     VSDYINANII MPEFETKCNN SKPKKSYIAT QGCLQNTVND FWRMVFQENS RVIVMTTKEV
     ERGKSKCVKY WPDECALKEY GVMRVRNVRE SAAHDYTLRE LKLSKVGQGN TERTVWQYHF
     RTWPDHGVPS DPGGVLDFLE EVHHKQESIV DAGPVVVHCS AGIGRTGTFI VIDILIDIIR
     EKGVDCDIDV PKTIQMVRSQ RSGMVQTEAQ YRFIYMAVQH YIETLQRRIE EEQKSKRKGH
     EYTNIKYSLV DQTSGDQSPL PPCTPTPPCA EMREDSARVY ENVGLMQQQR SFR
//
